Abemaciclib-based therapy versus tucidinostat-based therapy in patients with HRHER2 metastatic breast cancer after palbociclib progression: insights and challenges from a comparative cohort study in China.
作者信息
Balanchivadze Nino, Robert Nicholas J
机构信息
Virginia Oncology Associates/US Oncology Network, Norfolk, VA, USA.
Ontada, Boston, MA, USA.
出版信息
Transl Breast Cancer Res. 2023 Oct 23;4:32. doi: 10.21037/tbcr-23-45. eCollection 2023.
Abstract
摘要
Zotero 插件